Scientific Publications

As a collective of scientists with a strong academic background,
Profil Institute's clinical researchers continue to contribute to the scientific community through publishing and conference participation.

Most recent publications:
 

1. Andrew J. Krentz, Marcus Hompesch
   Future Treatments for Type 2 Diabetes
   Treatment Strategies Diabetes 2011: 3(1): 41-49
2. Morrow L, Hompesch M, Tideman AM, Matson J, Dunne N, Pardo S, Parkes JL, Schachner HC, Simmons DA.
   Evaluation of a Novel Continuous Glucose Measurement Device in Patients with Diabetes Mellitus
   across the Glycemic Range.
   J Diabetes Sci Technol. 2011;5(4):853-859.
3. Morrow L, Muchmore DB, Ludington EA, Vaughn DE, Hompesch M.
   Reduction in Intrasubject Variability in the Pharmacokinetic Response to Insulin After Subcutaneous Co-Administration with Recombinant Human Hyaluronidase in Healthy Volunteers.
   Diabetes Technol Ther. 2011 Jun 29. [Epub ahead of print]
4. Kauh EA; Mixson LA; Shankar S; McCarthy J; Maridakis V; Morrow L; Heinemann L; Ruddy MK; Herman GA; Kelley DE; Hompesch M.
   Short-term metabolic effects of prednisone administration in healthy subjects.
   Diabetes Obes Metab. 2011 Jun 2. doi: 10.1111/j.1463-1326.2011.01432.x. [Epub ahead of print]
5. Heinemann, L; Hompesch, M.
   Biosimilar Insulins: How Similar is Similar?
   J Diabetes Sci Technol. 2011;5(3):741-754
6. Pettis Ronald J; Ginsberg Barry; Hirsch Laurence; Sutter Diane; Keith Steven; McVey Elaine; Harvey Noel G; Hompesch Marcus; Nosek Leszek; Kapitza Christoph; Heinemann Lutz
   Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection
   Diabetes technology & therapeutics 2011;13(4):435-42
7. Judge K; Morrow L; Lastovich A; Kurisko D; Keith S; Hartsell J; Roberts B; McVey E; Weidemeaier K; Win K; Hompesch M
   Continuous Glucose Monitoring Using a Novel Glucose/Galactose Binding Protein: Result of a 12-Hour feasibility Study with the becton Dickinson Glucose/Galactose Binding Protein Sensor
   Diabetes Technology & Therapeutics 2011. Vol.13, No.3
8. Hompesch Marcus; Muchmore Douglas B; Morrow Linda; Vaughn Daniel E
   Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase
   Diabetes care 2011;34(3):666-8.
9. Morrow L; Hompesch M; Guthrie H; Chang D; Chatterjee D J
   Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction.
   Diabetes, obesity & metabolism 2011;13(1):75-80.
10. Ocheltree S, Hompesch M, Wondmagegnehu E, Morrow L, Win K,
    Jacober S.
    Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.
    Eur J Endocrinol. 2010. 163(2):217-23
11. Kempe K, Price D, Ellison J, Marhoul J, Morrow L, Win K, Kuschma K, Hompesch M.
    Capillary and venous blood glucose concentrations measured during intravenous insulin and glucose infusion: a comparison of steady and dynamic states.
    Diabetes Technol Ther, 2009. 11(10): p. 669-74.
12. Hompesch M, Ocheltree SM, Wondmagegnehu ET, Morrow LA, Kollmeier AP, Campaigne BN, Jacober SJ.
    Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes.
    Curr Med Res Opin, 2009. 25(11): p. 2679-2687.
13. Hompesch M, Kollmeier A, Rave K, Heinemann L, Mitnick M, Davies S,
    Strack T.
    Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes.
    Diabetes Technol Ther, 2009. 11(5): p. 307-13.
14. Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, Pfuetzner A, Heinemann L. 
    A novel insulin formulation with a more rapid onset of action.
    Diabetologia, 2008. 51(9): p. 1602-1606.
15. Hompesch M, Rave K.
    An analysis of how to measure glucose during glucose clamps: are glucose meters ready for research?
    J Diabetes Sci Technol, 2008. 2(5): p. 896-898.
16. Heinemann Lutz; Hompesch Marcus
    Role of physicians in the pharmaceutical industry and clinical research organizations: take more pride in your work.
    J Diabetes Sci Technol 2008;2(4):707-9
17. Hompesch Marcus; McManus Laura; Pohl Roderike; Simms Patrick; Pfützner Andreas; Bülow Elena; Flacke Frank; Heinemann Lutz; Steiner Solomon S
    Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin.
    J Diabetes Sci Technol, 2008;2(4):568-71.

Looking for a manuscript published by Profil Institute's scientific team
or a list of publications from one of our scientists?
Please contact us for information:

bd@profilinstitute.com